Dabur India reported an 11% year-on-year revenue increase to Rs 37.6 billion in the first quarter of FY27. Despite rising costs and unpredictable weather, the company maintains its guidance for double-digit revenue growth for the full year. Investors are now tracking how the company's premiumization strategy and rural demand expansion will impact its profit margins.
Dabur India posted consolidated revenue of Rs 37.6 billion for the quarter ended June 2026, marking an 11% increase compared to the same period last year. The company’s performance highlights its ability to navigate a complex environment marked by fluctuating input costs and challenging weather patterns that affected consumer buying habits in certain regions.
The India fast-moving consumer goods segment saw a 5% increase in volume during the quarter. A key driver for this performance was the healthcare products division, which recorded double-digit growth. The food and beverages business also showed signs of recovery as the quarter progressed, particularly during the months of May and June, helping offset earlier weather-related setbacks.
Management has maintained its outlook for double-digit consolidated revenue growth for fiscal year 2027. This strategy relies heavily on the 'Project Saksham' initiative, which aims to improve the company’s reach and efficiency in getting products to retail stores. By focusing on higher-value products and continuous innovation, the company intends to stay competitive against other major players in the consumer goods space.
While revenue trends appear steady, the company faces pressure from volatile raw material costs, which can squeeze operating profit margins if pricing power remains limited. Historically, the company has managed these costs by adjusting product prices and optimizing manufacturing expenses, though investors often monitor these trends to see if margin expansion matches the growth in sales.
Valuation models for Dabur India, including recent updates from analysts, reflect a shift toward a 42 times multiple on estimated earnings for fiscal year 2028. This adjustment factors in the current macroeconomic climate and the company's reliance on premium products to drive earnings. Compared to some peers in the FMCG sector, Dabur’s diverse portfolio in healthcare and home care products provides a different risk profile, as it is less dependent on pure discretionary spending.
The next steps for investors will involve tracking rural versus urban consumption patterns, as rural markets have recently shown faster growth than urban centers. Additionally, updates on how successfully the company manages its input costs while maintaining volume growth under the new go-to-market strategy will be central to its financial health in the coming quarters.